NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Dukagjin M Blakaj
Ohio State University - Columbus / United States
Medical and Health Sciences / Radiation Oncology
AD Scientific Index ID: 885123
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Dukagjin M Blakaj's MOST POPULAR ARTICLES
1-)
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trialML Gillison, AM Trotti, J Harris, A Eisbruch, PM Harari, DJ Adelstein, ...The Lancet 393 (10166), 40-50, 20198272019
2-)
Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002)SS Yom, P Torres-Saavedra, JJ Caudell, JN Waldron, ML Gillison, P Xia, ...Journal of Clinical Oncology 39 (9), 956, 20211242021
3-)
Phase IIb, randomized, double-blind trial of GC4419 versus placebo to reduce severe oral mucositis due to concurrent radiotherapy and cisplatin for head and neck cancerCM Anderson, CM Lee, DP Saunders, A Curtis, N Dunlap, C Nangia, ...Journal of Clinical Oncology 37 (34), 3256, 2019992019
4-)
Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial dataA Blakaj, M Bonomi, ME Gamez, DM BlakajOral oncology 95, 29-34, 2019962019
5-)
Time to surgery and survival in head and neck cancerCJ Rygalski, S Zhao, A Eskander, KY Zhan, EA Mroz, G Brock, ...Annals of surgical oncology 28, 877-885, 2021852021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept